研究者一覧

小島　康幸Kojima Yasuyuki

■所属部署名	臨床ゲノム研究所
■職名	准教授

Last Updated :2025/04/01

BRCA1/2 reversion mutations in a pan-cancer cohort., Nakamura Kohei;Hayashi Hideyuki;Kawano Ryutaro;Ishikawa Marin;Aimono Eriko;Mizuno Takaaki;Kuroda Hajime;Kojima Yasuyuki;Niikura Naoki;Kawanishi Aya;Takeshita Kei;Suzuki Shinsuke;Ueno Shinichi;Okuwaki Kosuke;Sasaki Jiichiro;Yamaguchi Masatoshi;Masuda Kenta;Chiyoda Tatsuyuki;Yamagami Wataru;Okada Chihiro;Nohara Sachio;Tanishima Shigeki;Nishihara Hiroshi, Cancer science, 2023年12月, 原著, 査読あり, DOI:10.1111/cas.16033

Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast., Nagasawa Satoi;Kuze Yuta;Maeda Ichiro;Kojima Yasuyuki;Motoyoshi Ai;Onishi Tatsuya;Iwatani Tsuguo;Yokoe Takamichi;Koike Junki;Chosokabe Motohiro;Kubota Manabu;Seino Hibiki;Suzuki Ayako;Seki Masahide;Tsuchihara Katsuya;Inoue Eisuke;Tsugawa Koichiro;Ohta Tomohiko;Suzuki Yutaka, Communications biology, 4(1), 2021年04月, 原著, 査読あり

Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)., Futamura Manabu;Oba Mari;Masuda Norikazu;Bando Hiroko;Okada Morihito;Yamamoto Yutaka;Kin Takanori;Saeki Toshiaki;Nagashima Takeshi;Kuwayama Takashi;Toh Uhi;Hirano Akira;Inokuchi Masafumi;Yamagami Kazuhiko;Mizuno Yutaka;Kojima Yasuyuki;Nakayama Takahiro;Yasojima Hiroyuki;Ohno Shinji, Breast cancer (Tokyo, Japan), 28(5), 2021年04月, 原著, 査読あり

Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy., Ishitobi Makoto;Matsuda Naoko;Tazo Mizuho;Nakayama Sayuka;Tokui Ryu;Ogawa Tomoko;Yoshida Atsushi;Kojima Yasuyuki;Kuwayama Takashi;Nakayama Takahiro;Yamauchi Hideko;Nakamura Seigo;Tsugawa Koichiro;Hayashi Naoki, Annals of surgical oncology, 28(5), 2020年10月, 原著, 査読あり

Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)., Yamashita Toshinari;Masuda Norikazu;Saji Shigehira;Araki Kazuhiro;Ito Yoshinori;Takano Toshimi;Takahashi Masato;Tsurutani Junji;Koizumi Kei;Kitada Masahiro;Kojima Yasuyuki;Sagara Yasuaki;Tada Hiroshi;Iwasa Tsutomu;Kadoya Takayuki;Iwatani Tsuguo;Hasegawa Hiroki;Morita Satoshi;Ohno Shinji, Trials, 21(1), 2020年06月

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)., Yamashita Toshinari;Masuda Norikazu;Saji Shigehira;Araki Kazuhiro;Ito Yoshinori;Takano Toshimi;Takahashi Masato;Tsurutani Junji;Koizumi Kei;Kitada Masahiro;Kojima Yasuyuki;Sagara Yasuaki;Tada Hiroshi;Iwasa Tsutomu;Kadoya Takayuki;Iwatani Tsuguo;Hasegawa Hiroki;Morita Satoshi;Ohno Shinji, Trials, 21(1), 2020年05月, 原著, 査読あり

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer., Iwasa Tsutomu;Tsurutani Junji;Watanabe Satomi;Kato Ryoji;Mizuno Yutaka;Kojima Yasuyuki;Takashima Tsutomu;Matsunami Nobuki;Morimoto Takashi;Yamamura Jun;Ohtani Shoichiro;Tanabe Yuko;Yoshinami Tetsuhiro;Takano Toshimi;Komoike Yoshifumi;Nakagawa Kazuhiko, BMC cancer, 19(1), 2019年10月, 原著, 査読あり

Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society., Hojo Takashi;Masuda Norikazu;Iwamoto Takayuki;Niikura Naoki;Anan Keisei;Aogi Kenjiro;Ohnishi Tatsuya;Yamauchi Chisako;Yoshida Masayuki;Kinoshita Takayuki;Masuoka Hideji;Sagara Yasuaki;Sakatani Takashi;Kojima Yasuyuki;Tsuda Hitoshi;Kumamaru Hiraku;Miyata Hiroaki;Nakamura Seigo, Breast cancer (Tokyo, Japan), 27(1), 2019年07月, 原著, 査読あり

アベマシクリブ関連薬剤性肺障害のネステッドケースコントロール研究, 中山紗由香;吉沢あゆは;鶴谷純司;吉村健一;長瀬洋之;細永真理;小島康幸;平成人;相原智彦;木川雄一郎;向井博文, 日本乳癌学会総会プログラム抄録集, 2022年06月